Xtant Medical Holdings, Inc. Quarterly Selling and Marketing Expense in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Xtant Medical Holdings, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2010 to Q2 2024.
  • Xtant Medical Holdings, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $13.2M, a 51.2% increase year-over-year.
  • Xtant Medical Holdings, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $48.3M, a 76.1% increase year-over-year.
  • Xtant Medical Holdings, Inc. annual Selling and Marketing Expense for 2023 was $38.4M, a 70.7% increase from 2022.
  • Xtant Medical Holdings, Inc. annual Selling and Marketing Expense for 2022 was $22.5M, a 7.09% increase from 2021.
  • Xtant Medical Holdings, Inc. annual Selling and Marketing Expense for 2021 was $21M, a 0.2% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $48.3M $13.2M +$4.46M +51.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $43.8M $12.5M +$5.41M +76.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $38.4M $11.6M +$5.75M +98.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $32.7M $11.1M +$5.25M +89.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $27.4M $8.72M +$3.08M +54.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $24.4M $7.05M +$1.85M +35.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $22.5M $5.83M +$519K +9.77% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $22M $5.84M +$571K +10.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $21.4M $5.64M +$46K +0.82% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $21.4M $5.21M +$354K +7.29% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $21M $5.31M -$92K -1.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $21.1M $5.27M -$3K -0.06% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $21.1M $5.59M +$1.7M +43.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $19.4M $4.86M -$1.56M -24.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $21M $5.41M -$1.59M -22.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 $22.6M $5.27M -$1.42M -21.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $24M $3.9M -$2.18M -35.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $26.2M $6.41M -$329K -4.88% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $26.5M $6.99M +$271K +4.03% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 $26.2M $6.69M -$1.16M -14.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $27.4M $6.07M -$2.47M -28.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 $29.9M $6.74M -$1.61M -19.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $31.5M $6.72M -$2.75M -29% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $34.2M $7.85M -$1.06M -11.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $35.3M $8.55M -$2.59M -23.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $37.9M $8.35M -$2.65M -24.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $40.5M $9.47M -$2.41M -20.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $42.9M $8.9M -$2.34M -20.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $45.3M $11.1M +$717K +6.88% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $44.5M $11M +$484K +4.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $44.1M $11.9M +$1.33M +12.6% Oct 1, 2016 Dec 31, 2016 10-K/A 2018-04-05
Q3 2016 $42.7M $11.2M +$2.81M +33.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-21
Q2 2016 $39.9M $10.4M +$5.38M +107% Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-03-30
Q1 2016 $34.5M $10.5M +$5.8M +123% Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-03-30
Q4 2015 $28.7M $10.6M +$6.03M +133% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 $22.7M $8.43M +$4.5M +115% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $18.2M $5.04M +$630K +14.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $17.6M $4.71M +$658K +16.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 $16.9M $4.53M +$566K +14.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-24
Q3 2014 $16.3M $3.93M -$127K -3.12% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $16.5M $4.41M +$200K +4.75% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $16.3M $4.06M +$257K +6.76% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $16M $3.96M -$324K -7.56% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-18
Q3 2013 $16.3M $4.05M +$701K +20.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $15.6M $4.21M +$370K +9.65% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $15.3M $3.8M -$348K -8.39% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $15.6M $4.28M -$813K -15.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-27
Q3 2012 $16.4M $3.35M -$1.46M -30.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $17.9M $3.84M -$496K -11.5% Mar 31, 2012 Jun 30, 2012 10-Q 2012-08-10
Q1 2012 $18.4M $4.15M -$118K -2.77% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $18.5M $5.1M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-27
Q3 2011 $4.81M +$2.49M +107% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $4.33M +$2.65M +157% Mar 31, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 $4.26M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $2.32M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $1.68M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.